IMVT - Immunovant  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMVT is currently covered by 8 analysts with an average price target of $35.3. This is a potential upside of $13.65 (63.05%) from yesterday's end of day stock price of $21.65.

Immunovant 's activity chart (see below) currently has 144 price targets and 114 ratings on display. The stock rating distribution of IMVT is 88.24% BUY and 11.76% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 59.27% with an average time for these price targets to be met of 179.17 days.

Highest price target for IMVT is $61, Lowest price target is $16, average price target is $33.86.

Most recent stock forecast was given by DANIELLE BRILL from TRUIST on 13-Oct-2025. First documented stock forecast 06-Jan-2020.

Currently out of the existing stock ratings of IMVT, 15 are a BUY (88.24%), 2 are a HOLD (11.76%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$16

$-2.94 (-15.52%)

$36

16 days ago
(13-Oct-2025)

2/4 (50%)

$-1.49 (-8.52%)

35

Buy

$33

$14.06 (74.23%)

$37

1 months ago
(29-Sep-2025)

0/4 (0%)

$16.88 (104.71%)

Buy

$35

$16.06 (84.79%)

$51

1 months 26 days ago
(03-Sep-2025)

11/21 (52.38%)

$18.88 (117.12%)

268

Buy

$30

$11.06 (58.39%)

$33

2 months 18 days ago
(11-Aug-2025)

1/4 (25%)

$14.79 (97.24%)

126

Hold

$17

$-1.94 (-10.24%)

$41

6 months 8 days ago
(21-Apr-2025)

2/6 (33.33%)

$2.75 (19.30%)

41

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMVT (Immunovant ) average time for price targets to be met?

On average it took 179.17 days on average for the stock forecasts to be realized with a an average price target met ratio 59.27

Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?

GBOLA AMUSA

Which analyst has the most public recommendations on IMVT (Immunovant )?

Gbola Amusa works at CHARDAN CAPITAL and has 0 price targets and 0 ratings on IMVT

Which analyst is the currently most bullish on IMVT (Immunovant )?

Alex Thompson with highest potential upside - $42.06

Which analyst is the currently most reserved on IMVT (Immunovant )?

Tiago Fauth with lowest potential downside - -$11.94

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?